Description: Discuss a comparison of the U.S. general and insured population mortality experience and how COVID-19 and non-COVID-19 excess deaths impacted the populations differently. Discover the population mortality experience in the UK with a focus on the recent emergence of excess deaths for non-COVID causes. The long-term implications on the insured population will also be explored. Wrap up with a discussion of different conditions of long COVID, including organ impairments.

Description: The life insurance industry has been dealing with low interest rate environment for many years. As a result, investment incomes have been low but many have found ways to embrace and deal with it. Recently, the interest rates have started to increase and at times are moving rather rapidly. While a rise in interest rates is perceived as a good thing, a rapidly rising interest rate environment can be problematic. Additionally, is 'lower for longer' no longer the norm? Learn more about the recent trend of rising interest rates and what can actuaries do about it in consideration to pricing and risk management.

Description: Statutory and GAAP metrics are useful for regulators, investors, and other external parties who require a consistent basis for viewing snapshots of companies at a point in time, however, their uses are more limited for managers who are tasked with making strategic decisions. Many insurers are turning to internally developed metrics such as value of new business (VNB) for better profitability insights at the point of sale and to understand how new business profitability changes over time. By leveraging existing models and reporting processes, insurers can reduce the additional effort involved, applying VNB toward applications such as pricing, capital allocation, and risk management. Discuss key considerations for developing and using VNB. Begin with a brief overview of VNB, including how VNB addresses specific shortcomings of Stat and GAAP. Next, discuss applications of VNB for life and annuity business and conclude with some implementation case studies.

Description: In this session, you will be exposed to new innovations in the insurance industry around the world.

Description: Large SEC US GAAP filers implemented LDTI 1/1/2023. Other insurance companies have until 1/1/2025. Learn more about those companies with a 2025 implementation date. What do these companies need to know? What can be learned from the 2023 implementers? What are the biggest hurtles to implementation?

Description: Go over how the actuarial processes have changed over the past 10+ years with the move to PBR, US GAAP LDTI, IFRS 17 and other emerging requirements.

Description: Welcome to the appellate court. We’ve seen some scare in mass media on climate-linked mortality, but not sure what to make of that in our actuarial practice. Both data and research is quickly evolving around climate change’s impact globally and to US mortality. We’ll share a few tidbits from recent actuarial research on wildfires and air pollution in particular. At the same time, there are still many unknowns on the long-term effects, and this phase of understanding is ripe for calling on a diverse group of experts. We bring expert witnesses from different professions to the actuarial stand to answer whether climate change’s impacts from heat wildfire-induced air pollution to mental health is a credible and material threat to insured mortality. The audience should come ready to judge the arguments presented.

Description: The session will use a case study to discuss some of the nuances and general considerations for an MRB, FAS 133 and VOBA balances for a business combination for an fixed index annuity (FIA) contract. The case study will discuss some MRB fair value considerations and followed by FAS 133 fair value techniques.

Description: This session will showcase how from an actuarial perspective IFRS17 has its roots in market consistent valuations. It will also show how International Financial Reporting Standard (IFRS) 17 is rooted in probability-weighted stochastic scenarios-same as fair valuation, and how initial recognition sets the stage, as in the pricing basis and report, for actual experience to emerge as in the subsequent recognition. A detailed model will be given for a simple annual premium non-par endowment and actual numbers given and explained. The stochastic model will explain in detail the key reserve items in IFRS 17 including: - Liability for remaining coverage (LRC) - Risk Adjustment (RA) - Contractual Service Margin (CSM) And it will explain their interactions with one another. A discussion will be held regarding universal life policies with simple interest guarantees. And how these guarantees merit a valuation similar to Lookback options because of their path-dependent nature.

Description: As the industry has seen an increasing trend in asset allocations to private markets and structured credit investment over the past decade, this presentation aims to share the considerations and lessons learned from both asset manager and actuarial perspectives with regards to modeling and regulatory compliance. At the conclusion of this session, the attendees will gain an understanding of: 1. Overall industry trend in asset allocations and the underlying drivers of increasing allocation to complex assets2. The common types of complex assets, the unique characteristics and the associated challenges in pricing and performance monitoring 3. Actuarial modeling and regulatory reporting challenges and practical solutions under US and Bermuda regimes (e.g., PBR, AG53, CP2) 4. Ongoing monitoring of risks underlying complex assets